思益可（上海）生物科技有限公司负责人尤利亚妮·加格尔（Juliane Gagel）表示，微生物菌种在食品与 大健康领域应用不断拓展。中外企业在技术路径、应用侧重和细分场景上各具特色与互补空间，愿与中 国同行一起做大产业"蛋糕"，共同推动微生物创新，助力健康中国与可持续发展。"我们带来的不仅是 技术，更是对中国市场的长期承诺。"尤利亚妮·加格尔说。 据了解，思益可已与蒙牛等中国品牌展开合作，服务客户涵盖品牌方与代工厂。该企业将依托"双引擎 创新"模式，推动中欧科技深度融合：一方面设立联合研发平台，开发符合中国饮食文化与健康需求的 益生菌与发酵技术；另一方面开展中西结合的微生物组研究，将意大利发酵工艺与中国本土相结合，推 出更贴近本地市场的产品及方案。 （文章来源：新华财经） 据悉，萨科系统集团是国际知名生物技术企业，产品涵盖乳酸发酵剂、益生菌、后生元、酶制剂等，业 务遍及全球110多个国家和地区。该企业于2018年启动亚太战略，先后进入新加坡、日本、澳大利亚市 场，此次在上海开设分公司，标志其亚太"研发—生产—市场"一体化布局初步完成。 近年来，中国益生菌市场发展迅速，已成为全球最具活力的市场之一。根据研究机构 ...

Core Insights - The article discusses Shanghai's action plan for accelerating food technology innovation from 2026 to 2030, aiming to enhance the food industry's development through synthetic biology and digital manufacturing [1][2]. Group 1: Goals and Objectives - By 2027, the plan aims to achieve significant breakthroughs in synthetic biology food creation, including the development and approval of 3-5 new food raw materials, additives, and related products, as well as 1-2 special medical purpose formula foods [2]. - The initiative seeks to cultivate over 5 innovative enterprises with core food creation technologies and digital manufacturing capabilities, and establish a comprehensive standard system for food industry development [2]. Group 2: Long-term Vision - By 2030, the goal is to create a globally influential hub for food technology innovation, resulting in a safer, healthier, more convenient, and sustainable food innovation ecosystem [3]. - The plan includes forming an innovation enterprise cluster covering the entire food industry chain, nurturing 8-10 leading companies in specific segments, and promoting 1-2 synthetic biology food innovation companies to go public [3]. - The food industry output value is projected to exceed 150 billion yuan, alongside the establishment of a national-level nutrition and health industry cluster and new food pilot parks [3]. Group 3: Research and Development Focus - The plan emphasizes accelerating the exploration of new food raw materials, focusing on functional proteins, carbohydrates, and lipids, while also considering active substances, flavors, and colorants [5]. - It aims to enhance biosynthesis technology through the integration of synthetic biology and artificial intelligence, improving the performance and adaptability of standardized components and chassis cells [5]. - Support for the development of new food products includes alternative proteins, plant-based meats, 3D-printed foods, and other innovative food solutions to meet diverse consumer needs and sustainable development goals [5].

Core Viewpoint - The Shanghai Municipal Science and Technology Commission, along with multiple departments, has issued the "Action Plan for Accelerating Food Technology Innovation to Empower Industrial Development (2026-2030)", which emphasizes support for the research and development of new food products [1] Group 1: New Food Development - The plan focuses on the development of alternative proteins, artificial meat, artificial milk, 3D-printed foods, and algae-based products [1] - It aims to create products with physiological regulatory functions, including active peptides, engineered probiotics, prebiotics, postbiotics, and food-medicine homologous products [1] - The initiative seeks to meet diverse food consumption needs, personalized nutrition and health demands, and sustainable development requirements [1]

Core Viewpoint - Keta Bio (300858) has obtained a food production license for its wholly-owned subsidiary in Inner Mongolia, expanding its business into probiotics and related products [1] Group 1: Business Expansion - The company will gradually release production capacity based on customer orders [1] - The product range includes probiotic raw materials, yogurt fermentation agents, postbiotics, and end-consumer probiotic products [1] Group 2: Market Strategy - The company is focusing on online market opportunities and has initiated compliant promotion and brand building on mainstream platforms [1] - Keta Bio is exploring live e-commerce and collaborations with influencers to enhance brand reputation and create popular products [1] - The goal is to continuously improve market influence [1]

Core Viewpoint - The company has obtained a food production license, indicating a significant step in its strategic planning and product development in the probiotics market [1] Group 1: Company Developments - The company's wholly-owned subsidiary, Inner Mongolia Ketaobiotechnology Co., Ltd., has acquired the food production license, which allows it to produce probiotic raw materials, yogurt fermentation agents, postbiotics, and probiotic consumer products [1] - The company plans to gradually release production capacity based on customer orders, ensuring an orderly production process [1] Group 2: Market Strategy - The company is focusing on online market opportunities and has initiated compliant promotion and brand building on mainstream platforms [1] - The company is exploring collaborations with live-streaming e-commerce and influencers to create popular products and enhance market influence [1]